Webbmedical necessity for requested iron preparation. AND 4. FOR INJECTAFER OR MONOFERRIC: Documentation of member’s current weight (within the last 30 days) CONTINUATION OF THERAPY: A. FOR ALL INDICATIONS: 1. Documentation of labs, chart notes documenting additional need due to continued low hemoglobin levels … WebbFeraheme (ferumoxytol), Injectafer (ferric carboxymaltose), and Monoferric (ferric derisomaltose) are proven for the following indications: Iron Deficiency Anemia (IDA) …
Intravenous Iron Replacement Therapy (Feraheme®, Injectafer ...
WebbVenofer ® (iron sucrose) injection, USP is an established and effective treatment for chronic kidney disease (CKD) patients experiencing iron deficiency anemia (IDA). … WebbFeraheme (ferumoxytol), Injectafer (ferric carboxymaltose), and Monoferric (ferric derisomaltose) are proven for the following indications: Iron Deficiency Anemia (IDA) … peroneal tendon tear test
NCD - Intravenous Iron Therapy (110.10) - Centers for …
WebbFeraheme and Injectafer are medically necessary when the following criteria are met: o For initial therapy, all of the following: Diagnosis of IDA and CKD; and Submission of medical records (e.g., lab values, chart notes, etc.) supporting the diagnosis of IDA; and Patient does not have ESRD; and WebbThe restricted product(s) may be considered medically necessary when the following criteria are met: 1. The requested agent is ferric carboxymaltose (Injectafer) or ferric derisomaltose (Monoferric); AND a. ONE of the following: i. The patient has tried and had an inadequate response to oral iron therapy used for at least 3 months [medical record WebbInfertility injectable medications are covered only when required by regulation or covered by a specific benefit design. Steroids are not covered for the enhancement of performance, as this is not considered treatment of disease. Note: Some state-to-state and plan type variations exist. peroneal tendon strengthening